Methylprednisolone sodium succinate liposomal - LipoCure

Drug Profile

Methylprednisolone sodium succinate liposomal - LipoCure

Alternative Names: LC 200

Latest Information Update: 22 Apr 2016

Price : $50

At a glance

  • Originator LipoCure
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antirheumatics; Corticosteroids
  • Mechanism of Action Immunosuppressants; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Falciparum malaria; Leukaemia; Multiple sclerosis; Optic neuritis; Rheumatoid arthritis; Systemic lupus erythematosus

Most Recent Events

  • 22 Apr 2016 Chemical structure information added
  • 18 Apr 2016 Preclinical trials in Falciparum malaria in Israel (IV) before April 2016
  • 18 Apr 2016 Preclinical trials in Leukaemia in Israel (IV) before April 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top